BioGenex, Inc. and Abbott Molecular, Inc. Conclude Successful Partnership
3/4/2013 10:07:05 AM
More...
|
Abbott Laboratories (ABT), BioGenex, Inc. Extend the Technology Co-development and Distribution Agreement for Marketing the Xmatrx(R) Advanced Staining Platform for the Automation of FISH, IHC and ISH Molecular Diagnostic Assays
6/2/2009 7:26:20 AM
More...
|
BioGenex, Inc., Ventana Medical Systems, Inc. (VMSI) Settle Patent Litigation
6/4/2007 10:37:34 AM
More...
|
BioGenex, Inc.'s Xmatrx(TM) System Provides Significant Advantage For Research
11/15/2005 1:45:14 PM
More...
|
Microtome To Microscope - The Xmatrx(TM) System From BioGenex, Inc.
11/8/2005 1:49:00 PM
More...
|
BioGenex, Inc. To Launch The Xmatrx(TM) Automated Staining System
11/1/2005 1:19:12 PM
More...
|
Federal Court Victory For BioGenex, Inc. On Patent Infringement Suit Against Ventana Medical Systems, Inc. (VMSI)
10/19/2005 5:13:23 PM
More...
|
FDA Approves BioGenex, Inc. InSite(TM) HER-2/Neu (CB11) Monoclonal Antibody
10/19/2005 5:13:17 PM
More...
|
BioGenex, Inc. Obtains Favorable Patent Ruling Against Ventana Medical Systems, Inc. (VMSI)
10/19/2005 5:13:17 PM
More...
|
BioGenex, Inc. Announces The Launch Of The Xmatrx(TM): A Walk-Away System For Total Automation Of FISH, ISH, And IHC For Molecular Diagnostics And Drug Target Identification And Validation
10/19/2005 5:13:08 PM
More...
|
|